Steve Oesterle

Position	Company	Period
Director	HeartWare International Inc	Jan. 18, 2016 -
Independent Director	Baxter International Inc	Feb. 6, 2017 -
Director	REVA Medical Inc	Feb. 5, 2018 - Jan. 1, 2019

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-05-18	2026-05-18	Baxter International Inc (BAX)	PrS Proposed sale	86,202 488.28 US$4,370,855	86,202	488.28	US$4,370,855